Your browser doesn't support javascript.
loading
Development of a Liver Disease-Specific Large Language Model Chat Interface using Retrieval Augmented Generation.
Ge, Jin; Sun, Steve; Owens, Joseph; Galvez, Victor; Gologorskaya, Oksana; Lai, Jennifer C; Pletcher, Mark J; Lai, Ki.
Afiliación
  • Ge J; Division of Gastroenterology and Hepatology, Department of Medicine, University of California - San Francisco, San Francisco, CA.
  • Sun S; UCSF Health Information Technology, University of California - San Francisco, San Francisco, CA.
  • Owens J; UCSF Health Information Technology, University of California - San Francisco, San Francisco, CA.
  • Galvez V; UCSF Health Information Technology, University of California - San Francisco, San Francisco, CA.
  • Gologorskaya O; UCSF Health Information Technology, University of California - San Francisco, San Francisco, CA.
  • Lai JC; Bakar Computational Health Sciences Institute, University of California - San Francisco, San Francisco, CA.
  • Pletcher MJ; Division of Gastroenterology and Hepatology, Department of Medicine, University of California - San Francisco, San Francisco, CA.
  • Lai K; Department of Epidemiology and Biostatistics, University of California - San Francisco, San Francisco, CA.
medRxiv ; 2023 Nov 10.
Article en En | MEDLINE | ID: mdl-37986764
ABSTRACT

Background:

Large language models (LLMs) have significant capabilities in clinical information processing tasks. Commercially available LLMs, however, are not optimized for clinical uses and are prone to generating incorrect or hallucinatory information. Retrieval-augmented generation (RAG) is an enterprise architecture that allows embedding of customized data into LLMs. This approach "specializes" the LLMs and is thought to reduce hallucinations.

Methods:

We developed "LiVersa," a liver disease-specific LLM, by using our institution's protected health information (PHI)-complaint text embedding and LLM platform, "Versa." We conducted RAG on 30 publicly available American Association for the Study of Liver Diseases (AASLD) guidelines and guidance documents to be incorporated into LiVersa. We evaluated LiVersa's performance by comparing its responses versus those of trainees from a previously published knowledge assessment study regarding hepatitis B (HBV) treatment and hepatocellular carcinoma (HCC) surveillance.

Results:

LiVersa answered all 10 questions correctly when forced to provide a "yes" or "no" answer. Full detailed responses with justifications and rationales, however, were not completely correct for three of the questions. Discussions In this study, we demonstrated the ability to build disease-specific and PHI-compliant LLMs using RAG. While our LLM, LiVersa, demonstrated more specificity in answering questions related to clinical hepatology - there were some knowledge deficiencies due to limitations set by the number and types of documents used for RAG. The LiVersa prototype, however, is a proof of concept for utilizing RAG to customize LLMs for clinical uses and a potential strategy to realize personalized medicine in the future.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: MedRxiv Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: MedRxiv Año: 2023 Tipo del documento: Article País de afiliación: Canadá